Del Pino Bellido Pilar, Guerra Veloz María Fernanda, Cordero Ruiz Patricia, Bellido Muñoz Francisco, Vega Rodríguez Francisco, Caunedo Álvarez Ángel, Carmona Soria Isabel
Aparato Digestivo, Hospital Universitario Virgen Macarena, España.
Aparato Digestivo, Hospital Universitario Virgen Macarena, ESPAÑA.
Rev Esp Enferm Dig. 2021 Dec;113(12):833-839. doi: 10.17235/reed.2020.7573/2020.
several barriers remain in the hepatitis C care cascade, which need to be removed in order to eliminate chronic hepatitis C. These barriers include deficiencies in screening and confirmatory diagnosis as well as difficulties in accessing treatment.
to identify factors associated with the non-referral of patients with positive hepatitis C virus (HCV) antibodies and to identify factors associated with loss of follow-up or non-attendance of these patients to specialist consultation after referral.
observational and retrospective single-center-study, including all positive HCV serology tests performed between January 2013 and May 2018, in the Virgen Macarena health area (Seville, Spain) before implementing the one-step diagnosis. Non-referred patients and patients who were lost to follow-up after being referred were identified.
a total of 54 (77.4 %) patients diagnosed in Primary Care (PC) and 54 (22.2 %) from hospital specialists were not referred (p < 0.001). Predictors for non-referral were: stay in prison/institutionalization (p = 0.04), suffering chronic obstructive pulmonary disease (COPD) (p = 0.07), a normal AST value (p = 0.034) or test requested by Primary Care physician (PCP) (p = 0.004). Patients referred from PC were more likely to be lost to follow-up than those referred from hospital specialists (p < 0.001). Predictors of follow-up loss included: opioid replacement therapy (p = 0.034), absence of high blood pressure (p = 0.039) and test requested by PCP (p = 0.049).
a high percentage of patients with positive HCV serology were not referred or were lost to follow-up, mainly those belonging to high risk social groups or those with associated comorbidities. Patients with average values of transaminases or those diagnosed in PC were also less frequently referred.
丙型肝炎治疗流程中仍存在若干障碍,为消除慢性丙型肝炎需加以消除。这些障碍包括筛查和确诊诊断方面的不足以及获得治疗的困难。
确定与丙型肝炎病毒(HCV)抗体阳性患者未被转诊相关的因素,并确定这些患者在转诊后失去随访或未前往专科会诊的相关因素。
进行观察性和回顾性单中心研究,纳入2013年1月至2018年5月在西班牙塞维利亚的比贞·马卡雷纳健康区实施一步诊断之前进行的所有HCV血清学检测阳性病例。确定未被转诊的患者以及转诊后失去随访的患者。
共有54例(77.4%)在初级保健机构(PC)诊断的患者和54例(22.2%)来自医院专科医生诊断的患者未被转诊(p<0.001)。未被转诊的预测因素为:入狱/机构收容(p=0.04)、患有慢性阻塞性肺疾病(COPD)(p=0.07)、AST值正常(p=0.034)或由初级保健医生(PCP)要求检测(p=0.004)。与从医院专科医生处转诊的患者相比,从PC转诊的患者更易失去随访(p<0.001)。随访丢失的预测因素包括:阿片类药物替代疗法(p=0.034)无高血压(p=0.039)以及由PCP要求检测(p=0.049)。
HCV血清学检测阳性的患者中有很大比例未被转诊或失去随访,主要是那些属于高风险社会群体或伴有合并症的患者。转氨酶值正常的患者或在PC诊断的患者也较少被转诊。